Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Opko pays $10mm in cash for oligonucleotide developer Curna

Executive Summary

Opko Health Inc. (devices, vaccines, and diagnostics) has paid $10mm in cash for private oligonucleotide start-up Curna Inc.
Deal Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Full Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register